Non-Melanoma Skin Cancer (NMSC) Recruiting Phase 1 / 2 Trials for Nivolumab (DB09035)

Also known as: Non-Melanoma Skin Cancer

IndicationStatusPhase
DBCOND0058473 (Non-Melanoma Skin Cancer (NMSC))Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03767348Study of RP1 Monotherapy and RP1 in Combination With NivolumabTreatment